Show simple item record

dc.contributor.authorCastanon, Alejandra
dc.contributor.authorRebolj, Matejka
dc.contributor.authorBurger, Emily Annika
dc.contributor.authorde Kok, Inge M. C. M.
dc.contributor.authorSmith, Megan A.
dc.contributor.authorHanley, Sharon J. B.
dc.contributor.authorCarozzi, Francesca Maria
dc.contributor.authorPeacock, Stuart
dc.contributor.authorO'Mahony, James F.
dc.date.accessioned2023-11-04T00:07:31Z
dc.date.available2023-11-04T00:07:31Z
dc.date.issued2021-07-01
dc.identifier226325426
dc.identifier568caf9c-7b3e-4695-bd62-edf1f1eff0f5
dc.identifier85108554277
dc.identifier.citationCastanon , A , Rebolj , M , Burger , E A , de Kok , I M C M , Smith , M A , Hanley , S J B , Carozzi , F M , Peacock , S & O'Mahony , J F 2021 , ' Cervical screening during the COVID-19 pandemic : optimising recovery strategies. ' , The Lancet Public Health , vol. 6 , no. 7 , pp. e522-e527 . https://doi.org/10.1016/S2468-2667(21)00078-5en
dc.identifier.issn2468-2667
dc.identifier.otherRIS: urn:88EA5D1EDBDD4AF4CE7F4CB6E0A2D2D7
dc.identifier.otherORCID: /0000-0002-7554-004X/work/127304252
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/19896
dc.descriptionAcknowledgments This work was done on behalf of the Screening Working Group of the COVID-19 and Cancer Global Modelling Consortium (CCGMC) and we acknowledge all members of the CCGMC Steering Committee, Secretariat, and Working Group 2. This work was supported by Ireland's Health Research Board (grant number EIA-2017–054 to JFOM), the National Health and Medical Research Council (Australia; grant APP1159491 to MAS), Cancer Research UK (grant number C8162/A27047 to MR and AC), Cancer Institute NSW (ECF181561 to MAS), National Institutes of Health (USA; U01CA199334 to EAB), Norwegian Cancer Society (#198073 to EAB), and the National Cancer Centre (Japan; 31-A-20 to SJBH). These funders had no role in directing or the writing of the manuscript, or the decision to submit for publication.en
dc.format.extent6
dc.format.extent94217
dc.language.isoeng
dc.relation.ispartofThe Lancet Public Healthen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectFemaleen
dc.subjectHumansen
dc.subject*COVID-19en
dc.subject*Early Detection of Canceren
dc.subject*Mass Screeningen
dc.subject*Pandemicsen
dc.subjectHealth Services Accessibilityen
dc.subjectHealthcare Disparitiesen
dc.subjectSARS-CoV-2en
dc.subjectUterine Cervical Neoplasms/*diagnosisen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleCervical screening during the COVID-19 pandemic : optimising recovery strategies.en
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Women’s Health Researchen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.1016/S2468-2667(21)00078-5
dc.identifier.vol6en
dc.identifier.iss7en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record